LOGIN
Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain
August 2021
Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain
Med J Aust. 2021 May;214(8): 370-375.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred patients with acute, non-traumatic low back pain presenting to the emergency department were randomized to receive a single-dose of oral cannabidiol (400mg) or placebo in addition to standard emergency department analgesic medication. The primary outcome of interest was pain score two hours after administration of the study agent on a verbal numerical pain scale. Secondary outcomes inc...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.